Stem Cells Translational Medicine最新文献

筛选
英文 中文
Temporal mapping of radiation-induced neural injury and mitigation in human cortical organoids. 人类皮质类器官辐射诱导的神经损伤及其缓解的时间图谱。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-08-18 DOI: 10.1093/stcltm/szag071
Ling He, Harley I Kornblum, Aparna Bhaduri, Frank Pajonk
{"title":"Temporal mapping of radiation-induced neural injury and mitigation in human cortical organoids.","authors":"Ling He, Harley I Kornblum, Aparna Bhaduri, Frank Pajonk","doi":"10.1093/stcltm/szag071","DOIUrl":"10.1093/stcltm/szag071","url":null,"abstract":"<p><strong>Background: </strong>Radiation therapy is a standard-of-care oncological treatment for central nervous system (CNS) malignancies. However, as survival outcomes improve, radiation-induced injury to normal brain tissue has increased in clinical significance. CNS radiation injury is a delayed, multifactorial process characterized by impaired neurogenesis, reactive gliosis, and persistent functional deficits. Mechanistic exploration and development of effective radiation mitigators have been limited by the lack of scalable, human-relevant models.</p><p><strong>Methods: </strong>Mature human iPSC-derived cortical organoids were exposed to single-dose or clinically relevant fractionated radiation (5 × 2 Gy). DNA damage, apoptosis, and growth dynamics were assessed longitudinally. Structural organization, synaptic integrity, and neuroinflammatory responses were evaluated by immunofluorescence and real-time PCR. Transcriptomic profiling was performed at 72 hours and 2 weeks after fractionated radiation to capture acute and delayed effects. Two candidate radiation mitigators, NSPP and amisulpride, were tested for their therapeutic effects within the organoid system.</p><p><strong>Results: </strong>Cortical organoids exhibited partial recovery following single doses up to 4 Gy or fractioned irradiation. Transcriptomic analyses revealed that radiation not only reduced overall cell viability but also reshaped lineage trajectories, characterized by depletion of neural stem/progenitor populations, loss of neuronal identity, enhanced gliogenesis, increased inflammatory cytokines, and disrupted cortical layering and synaptic integrity. Treatment with NSPP or amisulpride attenuated injury-associated transcriptional and structural alterations.</p><p><strong>Conclusion: </strong>Human cortical organoids recapitulate key features of radiation-induced neural injury, recovery, and therapeutic modulation, providing a robust, scalable, and human-relevant platform for studying CNS radiation biology and preclinical screening of candidate radiation mitigators.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 9","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13529364/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148866106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
M1-primed human corneal stromal stem cell-derived exosomes delivering protein-coding transforming growth factor-β3 RNA promote corneal regeneration. m1引发的人角膜基质干细胞来源的外泌体传递蛋白质编码转化生长因子-β3 RNA促进角膜再生。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-08-18 DOI: 10.1093/stcltm/szag079
Mithun Santra, Elizabeth Rubin, Syeda R Ali, Moira L Geary, Christine Chandran, Julia T Coelho, Ella J Dewald, Xi Cheng, Martha L Funderburgh, Deepinder K Dhaliwal, Xin D Gao, Vishal Jhanji, Gary H F Yam
{"title":"M1-primed human corneal stromal stem cell-derived exosomes delivering protein-coding transforming growth factor-β3 RNA promote corneal regeneration.","authors":"Mithun Santra, Elizabeth Rubin, Syeda R Ali, Moira L Geary, Christine Chandran, Julia T Coelho, Ella J Dewald, Xi Cheng, Martha L Funderburgh, Deepinder K Dhaliwal, Xin D Gao, Vishal Jhanji, Gary H F Yam","doi":"10.1093/stcltm/szag079","DOIUrl":"10.1093/stcltm/szag079","url":null,"abstract":"<p><strong>Introduction: </strong>Human corneal stromal stem cells (hCSSCs), which exhibit mesenchymal stem cell (MSC) features, prevent fibrotic scarring and promote regeneration of injured stromal tissue, thereby restoring corneal clarity in mice. These therapeutic effects rely on hCSSCs' ability to respond to early inflammatory cues, suppress chronic neutrophil infiltration, and inhibit fibrosis. In this study, we examined the responses of hCSSCs to transient pro-inflammatory M1 stimulation and characterized the exosomes (Exo) they secreted.</p><p><strong>Methods: </strong>We evaluated the expression of full-length protein-coding human TGFB3 mRNA molecules in purified Exo, and investigated Exo uptake, induction of human transforming growth factor β3 (hTGFβ3) protein expression, and the effects of different hTGFβ3/β1 ratios on myofibroblast generation from human corneal stromal keratocytes (CSKs) and stromal fibroblasts (SFs). The anti-scarring effect of hCSSC-Exo enriched in TGFB3 mRNA was assessed in a mouse model of acute corneal stromal injury.</p><p><strong>Results: </strong>Our results showed that hCSSC-Exo contained TGFB3 mRNA transcripts, and their abundance increased following pro-inflammatory M1 stimulation. Exo uptake enhanced hTGFβ3 protein expression in hCSKs, and a higher hTGFβ3/β1 ratio in hCSKs and hSFs suppressed expression of α-smooth muscle actin and TGFβ1-induced myofibroblast differentiation. In vivo, topical treatment with M1-primed hCSSC-Exo reduced corneal opacity compared with sham-treated controls. Notably, hCSSC-Exo enriched with TGFB3 mRNA demonstrated greater scar-reducing and wound-healing efficacy.</p><p><strong>Conclusions: </strong>M1-primed hCSSC-Exo containing protein-coding TGFB3 mRNA significantly inhibited corneal opacity and promoted scar-free healing in injured mouse corneas. These findings support the anti-fibrotic and regenerative potential of hCSSC-Exo, which can be developed as a cell-free therapeutic strategy for corneal fibrosis and scarring.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 9","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13543683/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148892407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum-induced recovery of proliferative capacity and differentiation potential in aged dental pulp stem cells. 血清诱导衰老牙髓干细胞增殖能力和分化潜能的恢复。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-08-18 DOI: 10.1093/stcltm/szag072
Cho-Yeon Park, Joung-Ho Moon, Sang-Man Lee, Eun-Hye Lee, Joo-Young Park, Sun-Young Kim
{"title":"Serum-induced recovery of proliferative capacity and differentiation potential in aged dental pulp stem cells.","authors":"Cho-Yeon Park, Joung-Ho Moon, Sang-Man Lee, Eun-Hye Lee, Joo-Young Park, Sun-Young Kim","doi":"10.1093/stcltm/szag072","DOIUrl":"10.1093/stcltm/szag072","url":null,"abstract":"<p><strong>Background: </strong>Aging impairs the proliferative, survival, and differentiation capacities of dental pulp stem cells (DPSCs), thereby limiting their regenerative potential. This study systematically investigated whether high-serum preconditioning could promote serum-induced recovery of age-associated functional decline in rat and human DPSCs.</p><p><strong>Methods: </strong>Young, older, and high-serum-conditioned DPSCs were compared using in vitro assays assessing proliferation, survival, colony-forming efficiency, and multilineage differentiation, together with in vivo functional regeneration models and transcriptomic profiling of human DPSCs.</p><p><strong>Results: </strong>High-serum preconditioning significantly enhanced proliferation and colony-forming efficiency in older DPSCs and restored osteogenesis and neurogenesis through serum-induced recovery, approaching the levels of young cells. In vivo, transplantation of high-serum-conditioned DPSCs resulted in organized axonal regeneration accompanied by compact myelin formation, as well as improved bone regeneration in calvarial defect models, demonstrating functional recovery beyond in vitro outcomes. Human DPSCs cultured under high-serum conditions similarly exhibited increased proliferation, viability, and lineage-specific differentiation capacity while maintaining stable expression of mesenchymal stem cell markers. Transcriptomic analysis revealed extensive remodeling under high-serum conditions, including activation of stemness- and cell cycle-related gene programs and suppression of senescence-associated transcripts. However, global gene expression patterns indicated only partial convergence toward a youthful transcriptional state rather than complete rejuvenation.</p><p><strong>Conclusions: </strong>High-serum preconditioning promotes serum-induced recovery and partially restores the regenerative competence of older DPSCs through reconfiguration of functional and molecular programs without full reversion to a youthful state. This study provides preliminary insight into serum-induced recovery and a framework for identifying serum-derived factors for future stem cell-based regenerative applications.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 9","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13505630/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148819493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stem cell-based therapeutics in epilepsy: current advances and future prospects. 干细胞治疗癫痫:当前进展和未来前景。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-08-18 DOI: 10.1093/stcltm/szag077
Napasiri Putthanbut, Jea-Young Lee, Cesario V Borlongan
{"title":"Stem cell-based therapeutics in epilepsy: current advances and future prospects.","authors":"Napasiri Putthanbut, Jea-Young Lee, Cesario V Borlongan","doi":"10.1093/stcltm/szag077","DOIUrl":"10.1093/stcltm/szag077","url":null,"abstract":"<p><p>Epilepsy represents as one of the most prevalent and serious neurological disorders, with approximately one-third of patients resistant to conventional treatments. Current pharmacologic therapies primarily suppress seizures without targeting the underlying epileptogenesis, resulting in unchanged long-term prognosis. At the same time, epilepsy surgery remains underutilized due to the requirement for extensive evaluations and specialized expertise. Stem cell-based therapy has emerged as a promising avenue, offering the potential to address both the neurological and neuropsychiatric aspects. This review summarizes recent preclinical and clinical studies on stem cell therapy in epilepsy, with a focus on their mechanisms of action, including direct engraftment, restoration of normal neurogenesis, and immunomodulation via bystander effect. Advances in genetic engineering, extracellular vesicle-based therapy, and patient-derived brain organoids offer more personalized treatment strategies. Although stem cell therapy holds significant promise as a treatment for epilepsy, further extensive research is required to establish its clinical safety and efficacy.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 9","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13544966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148892371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lysine methyltransferase methyltransferase-like 13 regulates bone marrow mesenchymal stem cells osteo-adipogenic differentiation and senescence in osteoporosis via the Foxa1/HES-1 axis. 赖氨酸甲基转移酶甲基转移酶样13通过Foxa1/HES-1轴调控骨质疏松症中骨髓间充质干细胞的成骨脂肪分化和衰老。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-07-20 DOI: 10.1093/stcltm/szag049
Ying Liu, Ao Wang, Ziwen Liu, Zhengwei Qin, Lei Yin, Xinyue Wang, Mingyu He, Tao Li, Yanquan Wang, Longhao Chen, Zhuo Liu, Jiayi Liu, Binsha Gu, Shichao Yang, Hui Liang, Yang Li, Xiaofei Zheng, Shuixing Zhang, Baofeng Yang, Ye Yuan, Lei Yang
{"title":"Lysine methyltransferase methyltransferase-like 13 regulates bone marrow mesenchymal stem cells osteo-adipogenic differentiation and senescence in osteoporosis via the Foxa1/HES-1 axis.","authors":"Ying Liu, Ao Wang, Ziwen Liu, Zhengwei Qin, Lei Yin, Xinyue Wang, Mingyu He, Tao Li, Yanquan Wang, Longhao Chen, Zhuo Liu, Jiayi Liu, Binsha Gu, Shichao Yang, Hui Liang, Yang Li, Xiaofei Zheng, Shuixing Zhang, Baofeng Yang, Ye Yuan, Lei Yang","doi":"10.1093/stcltm/szag049","DOIUrl":"10.1093/stcltm/szag049","url":null,"abstract":"<p><strong>Purpose: </strong>Recent research indicates that the senescence of bone marrow mesenchymal stem cells (BMSCs) disrupts the osteo-adipogenic balance, a primary factor contributing to the development of osteoporosis. Our previous findings have implicated methyltransferases in this process, among which methyltransferase-like 13 (METTL13) has been established to regulate cell fate, although its role in osteoporosis has yet to be determined.</p><p><strong>Methods: </strong>Bone formation was assessed using micro-computed tomography and hematoxylin and eosin staining. Protein expression in bone tissues was examined immunohistochemically, and cellular mRNA and protein levels were determined using quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and western blotting. Cellular senescence was evaluated based on β-galactosidase staining, and osteogenic and adipogenic differentiation was examined using alkaline phosphatase, Alizarin Red S, and Oil Red O staining. Protein interactions and DNA binding were determined using co-immunoprecipitation and chromatin immunoprecipitation.</p><p><strong>Results: </strong>METTL13 expression was significantly enhanced in ovariectomy-induced senescent bone and BMSCs, whereas METTL13 knockdown markedly reversed etoposide-induced cellular senescence. By binding to forkhead box protein A1 (Foxa1), METTL13 promotes the preferential differentiation of BMSCs into adipocytes, as opposed to osteocytes. Moreover, Foxa1 had effects opposite to those of METTL13 on BMSC differentiation, inhibiting the nuclear entry of METTL13. Notably, blocking the nuclear import of Foxa1 suppressed the transcriptional expression of HES-1, which promoted the adipogenic differentiation of BMSCs and inhibited osteogenic differentiation.</p><p><strong>Conclusions: </strong>Our findings in this study revealed the mechanisms whereby METTL13 promotes BMSC senescence and disrupts BMSC differentiation, on the basis of which, we identified the METTL13-Foxa1-HES-1 axis as a potential therapeutic target for treatment of osteoporosis.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 8","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13415456/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148607555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Red blood cell differentiation using canine-induced pluripotent stem cells. 利用犬诱导的多能干细胞分化红细胞。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-07-20 DOI: 10.1093/stcltm/szag058
Kazuto Kimura, Masaya Tsukamoto, Kohei Shishida, Hiroko Sugisaki, Jun Katahira, Miyuu Tanaka, Mitsuru Kuwamura, Amir Kol, Mika Okada, Minoru Iijima, Mahito Nakanishi, Kikuya Sugiura, Shingo Hatoya
{"title":"Red blood cell differentiation using canine-induced pluripotent stem cells.","authors":"Kazuto Kimura, Masaya Tsukamoto, Kohei Shishida, Hiroko Sugisaki, Jun Katahira, Miyuu Tanaka, Mitsuru Kuwamura, Amir Kol, Mika Okada, Minoru Iijima, Mahito Nakanishi, Kikuya Sugiura, Shingo Hatoya","doi":"10.1093/stcltm/szag058","DOIUrl":"10.1093/stcltm/szag058","url":null,"abstract":"<p><strong>Background: </strong>Red blood cell (RBC) transfusions are essential for treating various medical conditions, but global demand is difficult to meet due to a dwindling donor pool and compatibility issues. Pluripotent stem cells (PSCs) offer a promising alternative of blood dependent on volunteer donors for RBC production, and dogs serve as an excellent model for translational research due to their physiological and genetic similarities to humans.</p><p><strong>Methods: </strong>Canine induced pluripotent stem cells (ciPSCs) were differentiated toward hematopoietic and erythroid lineages. Differentiated cells were evaluated for hematopoietic marker expression, hemoglobinization, colony-forming capacity, enucleation, and hemoglobin gene expression. Glycophorin A (GYPA)-enhanced green fluorescent protein (EGFP) reporter ciPSC lines were generated using clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9-mediated genome editing to visualize GYPA expression during differentiation.</p><p><strong>Results: </strong>This study introduces a protocol for RBC differentiation using ciPSCs. We achieved generation of hemoglobinized RBCs, progressing through polychromatic and orthochromatic erythroblast-like stages. CiPSC-derived hematopoietic cells/RBCs were confirmed to have immature characteristics as determined by limited colony-forming capacities, low enucleation, and embryonic and fetal hemoglobin gene expression. Additionally, we created GYPA-EGFP reporter ciPSC lines using CRISPR-Cas9-mediated genome editing, enabling real-time visualization of GYPA expression. This innovation confirmed GYPA as a viable surface marker for ciPSC-derived RBCs.</p><p><strong>Conclusion: </strong>Our findings mark an initial step toward establishing a canine PSC-based erythroid differentiation system, providing a foundation for future improvements and exploration of applications for canine PSC-derived RBCs.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 8","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13381058/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148520995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: The global regulatory landscape of stem cell medical aesthetics: challenges, comparisons, and pathways to coordination. 修正:干细胞医学美学的全球监管格局:挑战、比较和协调途径。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-07-20 DOI: 10.1093/stcltm/szag066
{"title":"Correction to: The global regulatory landscape of stem cell medical aesthetics: challenges, comparisons, and pathways to coordination.","authors":"","doi":"10.1093/stcltm/szag066","DOIUrl":"10.1093/stcltm/szag066","url":null,"abstract":"","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 8","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13435802/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148674238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ghrelin and relamorelin counteract hypoglycemia in mice engrafted with congenital hyperinsulinism stem cell-derived islets. 胃促生长素和relamorelin对抗先天性高胰岛素症干细胞来源胰岛移植小鼠的低血糖。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-07-20 DOI: 10.1093/stcltm/szag055
Väinö Lithovius, Hossam Montaser, Jonna Saarimäki-Vire, Hazem Ibrahim, Tom Barsby, Diego Balboa, Timo Otonkoski
{"title":"Ghrelin and relamorelin counteract hypoglycemia in mice engrafted with congenital hyperinsulinism stem cell-derived islets.","authors":"Väinö Lithovius, Hossam Montaser, Jonna Saarimäki-Vire, Hazem Ibrahim, Tom Barsby, Diego Balboa, Timo Otonkoski","doi":"10.1093/stcltm/szag055","DOIUrl":"10.1093/stcltm/szag055","url":null,"abstract":"<p><strong>Introduction: </strong>KATP-channel-related hyperinsulinism (KATPHI) is a rare genetic disorder of the pancreatic beta cells, manifesting as life-threatening hypoglycemia in neonates due to excessive insulin secretion. Management of the severe diffuse form of KATPHI currently lacks treatment options, as the first-line therapy octreotide is often insufficiently effective, necessitating radical pancreatectomy in many patients.</p><p><strong>Methods: </strong>In this study, we differentiated stem cells carrying the KATPHI-causing mutation KCNJ11-/- to stem cell-derived islets (SC-islets) to develop new pharmaceutical therapies for KATPHI. We tested seven candidate molecules in vitro and the most effective ones in vivo in immunocompromised mice that were transplanted with the human KCNJ11-/- SC-islets.</p><p><strong>Results: </strong>KCNJ11 -/- SC-islets inappropriately secreted 3.9 times more insulin in low glucose than KCNJ11+/+ controls. Transplanted KCNJ11-/- SC-islets caused persistent hyperinsulinemia and hypoglycemia to the recipient mice. We tested acyl-ghrelin identified in our in vitro experiments and its long-acting analogue relamorelin in these mice. Acyl-ghrelin and relamorelin alone increased fasting blood glucose. Combining relamorelin with octreotide increased blood glucose synergistically, ie, more than the sum of each drug alone, reverting hypoglycemia to normoglycemia while reducing the excessive insulin secretion.</p><p><strong>Conclusions: </strong>We show that ghrelin-receptor agonists have acute anti-hypoglycemic effects in a humanized mouse model of KATPHI, especially when combined with octreotide. Relamorelin has been tested in >650 diabetic adults with little side effects, leading us to propose relamorelin-octreotide combination for further development as a therapeutic candidate for severe KATPHI patients.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 8","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13441175/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148679820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of infectious disease outbreaks and regulatory policies on cord blood banking: a two-decade single-center analysis in Korea. 传染病暴发和监管政策对脐带血银行的影响:韩国20年单中心分析。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-07-20 DOI: 10.1093/stcltm/szag059
Sue Shin, Nam-Hee Kim, Hye Ryun Lee, Jong Hyun Yoon, Byoung Jae Kim, Hyun-Woong Park, Eun Youn Roh
{"title":"Impact of infectious disease outbreaks and regulatory policies on cord blood banking: a two-decade single-center analysis in Korea.","authors":"Sue Shin, Nam-Hee Kim, Hye Ryun Lee, Jong Hyun Yoon, Byoung Jae Kim, Hyun-Woong Park, Eun Youn Roh","doi":"10.1093/stcltm/szag059","DOIUrl":"10.1093/stcltm/szag059","url":null,"abstract":"<p><p>Public cord blood (CB) banks face declining inventories worldwide, but the relative contributions of regulatory changes, declining birth rates, and infectious disease outbreaks remain unclear. We performed a retrospective analysis of 73 925 CB units submitted to a Korean public cord blood bank from 2006 to 2025, encompassing two regulatory transitions in total nucleated cell (TNC) criteria and three major outbreaks (H1N1, MERS, and COVID-19), using interrupted time series, correlation, and multivariable analyses. Of 73 925 submissions, 27 684 (37.4%) were banked. The 2011 TNC ≥ 8 × 108 criterion produced a moderate reduction in banking rate from 37.7% to 33.6%, while the 2021 TNC ≥ 11 × 108 revision caused an abrupt decline from 52.6% to 24.4%. H1N1 and MERS had minimal effects, whereas the COVID-19 period showed a sustained decline coinciding with the 2021 TNC revision. Birth decline correlated strongly with submissions (R2 = 0.94). Regulatory criteria changes were the primary driver of banking rate fluctuations, while declining births affected submission volume. Among three outbreaks, only the COVID-19 period overlapped with a sustained decline, likely reflecting concurrent regulatory change rather than the pandemic itself. CB quality and safety were maintained throughout all disruptions. These findings have direct translational implications for sustaining the global CB inventory as a critical source of hematopoietic stem cells for transplantation.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 8","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13441184/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148679874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stem cell-based therapies for neuroretinal degeneration: current landscape and future perspectives. 神经视网膜变性的干细胞治疗:现状和未来展望。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-07-20 DOI: 10.1093/stcltm/szag046
Sarah Saietz, Filippo Locri, Helena Isla-Magrané, Brandon Mills, Fredrik Lanner, Anders Kvanta
{"title":"Stem cell-based therapies for neuroretinal degeneration: current landscape and future perspectives.","authors":"Sarah Saietz, Filippo Locri, Helena Isla-Magrané, Brandon Mills, Fredrik Lanner, Anders Kvanta","doi":"10.1093/stcltm/szag046","DOIUrl":"10.1093/stcltm/szag046","url":null,"abstract":"<p><p>Retinal degenerations, comprising a heterogeneous group of disorders culminating in neuroretinal dysfunction, such as inherited retinal dystrophies (IRDs) and age-related retinal degeneration, are among the leading causes of irreversible vision loss worldwide. Restoring visual function through cell replacement therapy represents an attractive, yet challenging, strategy. Candidate retinal cell sources include retinal progenitor cells (RPCs), Müller glia, human neuroretinal stem-like cells (hNRSCs), and pluripotent stem cells (PSCs). In this review, we discuss their translational advantages and limitations, which in turn influence clinical implementation. We analyze critical manufacturing challenges, including GMP scalability, quality assurance, and ethical considerations in donor material sourcing. Experimental criteria for assessing cellular products' integration into host circuitry and their capacity to restore visual function in preclinical retinal degeneration models must account for donor maturity, host retina architecture, and immune modulation, which determine survival, synapse connectivity, and delivery requirements. Ongoing clinical trials highlight the diversity of cell replacement strategies-from fetal-derived and allogenic progenitor suspensions to laminated PSC-derived retinal sheets-with each approach presenting distinct implications for survival, true integration, and logistical complexity.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 8","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13405246/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148607600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书